CBDNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQX: CANSF) Releases Update on THC, Plans for Canadian Market Launch
Willow Biosciences (TSX: WLLW) (OTCQX: CANSF), a leading developer of biosynthetic production systems for high-value, plant-derived active pharmaceutical ingredients (“APIs”) and intermediates, has made advancements on its work on a proprietary yeast strain for the production of Tetrahydrocannabinol ("THC"); the company also announced plans to commercially launch the product in the highly regulated, legal Canadian market. Willow’s Canadian-based R&D (“R&D”) team has developed a proprietary yeast strain along with a process to produce THC; the company is eyeing a pilot scale run by the end of 2021. Willow is operating under the believe that a significant number of consumer product…